| Term 
 | Definition 
 
        | a polysaccharide of glucose, for short term energy, storage in liver and muscle tissue |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | catabolism of glycogen to glucose (breakdown of glycogen) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | rxns that convert glucose to pyruvic acid + ATP (energy for cells) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pancreatic hormone released when BG(blood glucose) low, causes liver to convert stored glycogen into glucose |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GI hormone causing an ↑ in the amount of insulin released by the beta cells after eating |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pancreatic peptide hormone secreted at the same time as insulin. "synergistic partner" contributing to glycemic control |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | d/o of carbohydrate metabolism. short term- hypo & hyper glycemia long term- HTN, heart disease; blindness; renal failure; neuropathy(nerve pain); amputations; impotence; stroke |  | 
        |  | 
        
        | Term 
 
        | signs and symptoms of diabetes mellitus(DM) |  | Definition 
 
        | undiagnosed s/s: sustained hyperglycemia; polyuria (↑ urine output); polydipsia (↑ fluid intake[excessive thirst]); ketonuria (ketones in urine); weight loss s/s result from a deficiency of insulin or resistance to insulin's actions. |  | 
        |  | 
        
        | Term 
 
        | types of diabetes mellitus (DM) |  | Definition 
 
        | type 1 (IDDM[insulin dependant diabetes mellitus], juvenile)- 5-10%- destruction of pancreatic beta cells (autoimmune process) type 2 (NIDDM[non-insulin dependant diabetes mellitus])- 22 millionamericans- insulin resistance & impaired insulin secretion gestational diabetes- appears during pregnancy, subsiding rapidly after delivery management: diet, exercise, medication (insulin, antihypertensives & cholesterol lower medications) glycemic index= regulation of blood glucose levels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | FSBG(finger stick blood glucose) & SMBG (self monitoring blood glucose): use a glucometer before meals (AC) & at bedtime (HS) Target: 70-130mg/dL (AC); 100-140 mg/dL (HS) |  | 
        |  | 
        
        | Term 
 
        | insulin type 1 and some type 2 stimulates cellular transport of glucose into the cells, and stored as glycogen; promotes synthesis of complex organic molecules |  | Definition 
 
        | can't give PO- destroyed by digestive system Use: diabetes; diabetic ketoacidosis; hyperkalemia Effects: lowers serum glucose levels AE: hypoglycemia; lipodystrophies[occurs when using same sit all the time](lipoatrophy & lipohypertrophy[enlargement of area]); allergic rxn; hypokalemia w/ excessive doses DD: hypoglycemic agents; hyperglycemic agents; ETOH(acute use); beta blockers(masks s/s of hypoglycemia); glucocorticoids; sympathomimetics |  | 
        |  | 
        
        | Term 
 
        | treating hypoglycemia(BG less < 50 mg/dL) |  | Definition 
 
        | Dextrose- IV; given for severe hypoglycemia; prefilled syringe Glucagon- insulin overdose; raises BG levels (promotes breakdown of glycogen synthesis & stimulates biosynthesis of glucose); use in unconscious patients. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | short duration, rapid acting: Humalog: onset- 15-30 min, duration- 3-6 hr; Novolog: onset- 10-20 min, duration- 3-5 hr; Apidra: onset 10-15 min, duration- 3-5 hr short duration, slower acting: Humilin R: onset- 30-60 min, peak: 1-5 hr, duration- 10 hr  all clear in color |  | 
        |  | 
        
        | Term 
 
        | intermediate duration insulin |  | Definition 
 
        | NPH: allergy potential (due to protamine-foreign protein); cloudy in color; only one that can be mixed w/ short duration insulin detemir(levemir): low doses- duration 12 hr; high doses- duration 24 hr |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | glargine(Lantus): only once daily 24 hr duration |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NPH & regular or Aspart protamine, Lispro protamine w/ aspart or lispro |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | injection site: upper arms, thighs, abdomen(prefered site); rotate sites w/in general area syringe & needle given in units. U100 or U500 pen injector- prefilled cartridge jet injector- no needle pumps- infusion SQ of regular, lispro, aspart or glulisine(short duration insulins). |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | causes: not eat enough, too much insulin or oral agent, too much activity s/s: shaking, ↑ HR, sweating, dizzy, faint, anxious, hungry, impaired vision, weakness & fatigue, HA(headache), emotional changes Tx: simple sugar followed w/ complex carbohydrate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | causes: too little insulin or oral agent, too much food s/s: extreme thirst, frequent urination, blurred vision, weakness & fatigue, HA, N, V, abd cramps, hunger followed by ↓ appetite Tx: insulin, fluids |  | 
        |  | 
        
        | Term 
 
        | metformin(glucophage) oral hypoglycemics- biguanides ↓ glucose production in liver; ↓ absorption of glucose in gut; enhances muscle utilization of glucose |  | Definition 
 
        | Use: type 2 diabetes Effects: lowers serum glucose levels AE: ↓ appetite, N, D; ↓ absorption of vitamin B12 & folic acid Toxicity: lactic acidosis by inhibition of oxidation of lactic acid (rare, but 50% mortality rate), usually r/t renal insufficiency DD: ETOH (↑ risk of lactic acidosis); IV contrast w/ iodine(↑ risk of lactic acidosis), stop 48 hr prior to test & restart 48 hr after procedure needs annual labs to check vitamin levels |  | 
        |  | 
        
        | Term 
 
        | tolbutamide (Orinase) oral hypoglycemic- sulfonylureas stimulates release of insulin from pancreas |  | Definition 
 
        | Use: type 2 diabetes; adjunct to diet/exercise program Effects: lowers serum glucose levels AE: hypoglycemia (fatigue, excessive hunger, profuse sweating, palpitations); avoid in pregnancy DD: ETOH (disulfiram-like rxn, intensify hypoglycemia); NSAIDs (intensify hypoglycemia); sulfonamide antibiotics (intensify hypoglycemia); beta blockers (supress insulin release |  | 
        |  | 
        
        | Term 
 
        | pioglitazone (Actos) glitazones aka TZDs ↓ insulin resistance |  | Definition 
 
        | Use: type 2 diabetes Effects: reduce blood glucose levels AE: URI(upper respiratory infection), HA, sinusitis (sinus infection), myalgia (tenderness or pain in the muscles); fluid retention, edema; raises HDL, LDL and ↓ triglycerides; less hepatotoxicity but monitor ATL (liver) levels DD: atorvastain (Lipitor) - leads to ↑ drug level and hypoglycemia if pt is premenopausal drug can stimulate ova production, leading to unplanned/unexpected pregnancy. |  | 
        |  | 
        
        | Term 
 
        | repaglinide (Prandin) glinides aka megalitinides stimulates release of insulin from pancreas |  | Definition 
 
        | Use: type 2 diabetes Effect: lowers serum glucose levels AE: hypoglycemia DD: gemfribrozil (Lopid) - inhibits metabolism of prandin leading to ↑ levels and hypoglycemia |  | 
        |  | 
        
        | Term 
 
        | acarbose (Precose) alpha-glucosidase inhibitor delays absorption of carbohydrates from intestine |  | Definition 
 
        | Use: type 2 diabetes Effects: reduces rise in blood glucose after meals AE: flatulence, cramps, abd distention, borborygmus (loud bowel sounds), D, liver dysfunction
 |  | 
        |  | 
        
        | Term 
 
        | sitagliptin (Januvia) gliptins (DPP-4 inhibitor) - new class prolongs active incretin levels, that ↑ insulin release and suppress release of glucagon |  | Definition 
 
        | Use: type 2 diabetes AE: HA, URI, hypoglycemia; rare: pancreatitis & severe hypersensitivity (allergic rxn) ADJUST DOSE IN RENAL FAILURE PATIENTS DD: none
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | T3 (triodothyonine - more potent) & T4 (tetraiodothyronine or thyroxine) stimulate energy use - ↑ basal metabolic rate, O2 use & heat production stimulate heart - ↑ HR & force of contraction, ↑ CO2, ↑ O2 demand promote growth & development - brain, nervous system & skeletal muscle low iodine - ↓ production of thyroid hormones; thyroid increases in size (goiter) & concentrates iodine |  | 
        |  | 
        
        | Term 
 
        | levothyroxine (Synthroid) synthetic preparation of thyroxine (T4) similar to thyroid hormone action |  | Definition 
 
        | Use: hypothyroidism Effects: ↑ thyroxine (T4) levels; ↑ T3 levels AE: thyrotoxicosis (excessive dosages) - tachycardia, angina (chest pain), tremors, nervousness, insomnia, hyperthermia, heat intolerance, diaphoresis (sweating) DD: drugs that ↓ levothyroxine absorption: H2 receptor blocker, PPI & Sulcralfate (GI protectant drugs); cholestyramine & cholestipol; calcium & Fe supplements; Mg salts phentoin (Dilantin), cambamazepine (Tegretol), seraline (Zoloft), phenobarbital ↑ metabolism of levothyroxine so may need to ↑ dose drug given in mcg; best absorbed on an empty stomach |  | 
        |  | 
        
        | Term 
 
        | methimazole (Tapazole) blockade of thyroid hormone synthesis; suppresses conversion of T4 to T3 |  | Definition 
 
        | Use: Grave's disease (hyperthyroidism); radiation therapy adjunct; pre-op in prep to remove portion of thyroid Effects: lower T3 & T4 levels AE: agranulocytosis (lack of WBCs); hypothyroidism; caution in pregnancy (crosses placenta and mammory glands); rash
 |  | 
        |  | 
        
        | Term 
 
        | propylthiouracil (PTU) used for emergencies |  | Definition 
 
        | Action and Effect similar to Tapazole Use: thyrotoxic crisis ("thyroid storm") AE: can cause liver injury
 |  | 
        |  | 
        
        | Term 
 
        | vasopressin (Pitressin) promotes renal conservation of H2O; vasoconstriction drug for hypothalamus d/o's |  | Definition 
 
        | Use: diabetes insipidus (ADH deficiency) Effects: ↓ diuresis (urine output) AE: H2O intoxication r/t excessive H2O retention (early s/s drowsiness, listless); HA; severe s/s: convlusions, terminal coma; cardiac - a.p. r/t coronary artery constriction
 |  | 
        |  | 
        
        | Term 
 
        | hydrocortisone (synthetic equivalent to cortisol), desamethasone, prednisone drug for adrenal d/o's |  | Definition 
 
        | Use: replacement therapy for adrenocortical insufficiency Effects: improve carbohydrate metabolism, promotes glucose availability to the brain AE: rare when used for endocrine d/o's
 |  | 
        |  | 
        
        | Term 
 
        | hormone replacement therapy |  | Definition 
 
        | estrogen, progestin & combo controversy r/t effects on uterine CA, breast CA, thromboembolism, ↑ bone density   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | conjugated estrogens (Premarin - from horse urine), Estradiol (Estrace) "Bio-identical hormones": estradiol, estriol, estrone used if women has no uterus |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Progesterone (Prometrium, medroxyprogesterone (Provera)) combination: Prempro pregestin and comvo given if uterus is present progestion protects endometrium to present hyperplasia and cancer |  | 
        |  |